N.E.W. Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
N.E.W. Advisory Services's BMY Position: Q2 2026 in Review
N.E.W. Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, selling an estimated $21.8K and leaving 1,766 shares worth $102K. The position accounts for 0.01% of the portfolio, ranked #290.
N.E.W. Advisory Services first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $130K in Q1 2026. 1,840 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- N.E.W. Advisory Services held 1,766 shares of Bristol-Myers Squibb worth $102K as of Q2 2026.
- N.E.W. Advisory Services sold 380 Bristol-Myers Squibb shares in Q2 2026, an estimated $21.8K.
- Bristol-Myers Squibb made up 0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #290 holding.
- N.E.W. Advisory Services first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
- N.E.W. Advisory Services's Bristol-Myers Squibb position peaked at $130K in Q1 2026.
- 1,840 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.